PA
HRMY icon

Profund Advisors’s Harmony Biosciences HRMY Stock Holding History

Profund Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Sell
9,495
-314
-3% -$9.9K 0.01% 719
2026
Q1 		$275K Buy
9,809
+1,595
+19% +$52.3K 0.01% 804
2025
Q4 		$307K Sell
8,214
-2,589
-24% -$85.1K 0.01% 852
2025
Q3 		$298K Buy
10,803
+520
+5% +$17.9K 0.01% 738
2025
Q2 		$325K Sell
10,283
-356
-3% -$11.5K 0.01% 646
2025
Q1 		$353K Sell
10,639
-440
-4% -$15.8K 0.02% 597
2024
Q4 		$381K Buy
11,079
+4,651
+72% +$160K 0.01% 654
2024
Q3 		$257K Sell
6,428
-1,129
-15% -$39.7K 0.01% 895
2024
Q2 		$228K Buy
7,557
+758
+11% +$22.8K 0.01% 909
2024
Q1 		$228K Sell
6,799
-4,718
-41% -$151K 0.01% 1009
2023
Q4 		$372K Buy
11,517
+3,187
+38% +$89K 0.02% 673
2023
Q3 		$273K Sell
8,330
-1,968
-19% -$68.3K 0.02% 709
2023
Q2 		$362K Buy
10,298
+287
+3% +$9.91K 0.02% 622
2023
Q1 		$327K Buy
10,011
+6,198
+163% +$282K 0.02% 676
2022
Q4 		$210K Buy
+3,813
New +$210K 0.01% 884

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Profund Advisors's HRMY Position: Q2 2026 in Review

Profund Advisors reduced its Harmony Biosciences (HRMY) stake by 3.2% in Q2 2026, selling an estimated $9.9K and leaving 9,495 shares worth $346K. The position accounts for 0.01% of the portfolio, ranked #719.

Profund Advisors first reported a position in HRMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $381K in Q4 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Profund Advisors held 9,495 shares of Harmony Biosciences worth $346K as of Q2 2026.
  • Profund Advisors sold 314 Harmony Biosciences shares in Q2 2026, an estimated $9.9K.
  • Harmony Biosciences made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #719 holding.
  • Profund Advisors first reported a position in Harmony Biosciences in Q4 2022 and has held it in 15 quarters since.
  • Profund Advisors's Harmony Biosciences position peaked at $381K in Q4 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.